Alkermes plc’s Market Journey: Closing Strong at 28.63, Up 4.37

Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.

The closing price of Alkermes plc (NASDAQ: ALKS) was $28.63 for the day, up 4.37% from the previous closing price of $27.43. In other words, the price has increased by $4.37 from its previous closing price. On the day, 1.31 million shares were traded. ALKS stock price reached its highest trading level at $28.725 during the session, while it also had its lowest trading level at $27.51.

Ratios:

Our analysis of ALKS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.65 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 9.85. For the most recent quarter (mrq), Quick Ratio is recorded 2.85 and its Current Ratio is at 3.23. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on July 15, 2025, initiated with a Buy rating and assigned the stock a target price of $43.

On June 17, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $42.

On May 28, 2025, Needham started tracking the stock assigning a Buy rating and target price of $45.Needham initiated its Buy rating on May 28, 2025, with a $45 target price.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jun 09 ’25 when Nichols Christian Todd sold 3,333 shares for $31.95 per share. The transaction valued at 106,489 led to the insider holds 89,542 shares of the business.

Nichols Christian Todd sold 3,334 shares of ALKS for $103,654 on Jun 10 ’25. The SVP, Chief Commercial Officer now owns 86,208 shares after completing the transaction at $31.09 per share. On Jun 10 ’25, another insider, Nichols Christian Todd, who serves as the Officer of the company, bought 3,334 shares for $31.09 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALKS now has a Market Capitalization of 4726182912 and an Enterprise Value of 3783121664. As of this moment, Alkermes’s Price-to-Earnings (P/E) ratio for their current fiscal year is 13.74, and their Forward P/E ratio for the next fiscal year is 17.94. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.14 while its Price-to-Book (P/B) ratio in mrq is 2.91. Its current Enterprise Value per Revenue stands at 2.513 whereas that against EBITDA is 9.381.

Stock Price History:

The Beta on a monthly basis for ALKS is 0.53, which has changed by 0.061156392 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, ALKS has reached a high of $36.45, while it has fallen to a 52-week low of $25.56. The 50-Day Moving Average of the stock is -0.36%, while the 200-Day Moving Average is calculated to be -5.03%.

Shares Statistics:

ALKS traded an average of 1.77M shares per day over the past three months and 1399570 shares per day over the past ten days. A total of 165.05M shares are outstanding, with a floating share count of 161.35M. Insiders hold about 2.26% of the company’s shares, while institutions hold 104.33% stake in the company. Shares short for ALKS as of 1753920000 were 13816459 with a Short Ratio of 7.81, compared to 1751241600 on 11863107. Therefore, it implies a Short% of Shares Outstanding of 13816459 and a Short% of Float of 12.1400006.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Earnings Estimates

Alkermes plc (ALKS) is presently subject to a detailed evaluation by 8.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.42, with high estimates of $0.54 and low estimates of $0.24.

Analysts are recommending an EPS of between $2.09 and $1.2 for the fiscal current year, implying an average EPS of $1.73. EPS for the following year is $1.52, with 9.0 analysts recommending between $1.96 and $0.17.

Revenue Estimates

It is expected that $90B in revenue will be generated in the current quarter, according to 16 analysts. It ranges from a high estimate of $369M to a low estimate of $340.54M. As of the current estimate, Alkermes plc’s year-ago sales were $378.14MFor the next quarter, 16 analysts are estimating revenue of $369.09M. There is a high estimate of $387.83M for the next quarter, whereas the lowest estimate is $338.4M.

A total of 16 analysts have provided revenue estimates for ALKS’s current fiscal year. The highest revenue estimate was $1.45B, while the lowest revenue estimate was $1.37B, resulting in an average revenue estimate of $1.42B. In the same quarter a year ago, actual revenue was $1.56BBased on 16 analysts’ estimates, the company’s revenue will be $1.44B in the next fiscal year. The high estimate is $1.53B and the low estimate is $1.32B.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.